Journal article icon

Journal article

Adherence and acceptability of once daily Lamivudine and abacavir in human immunodeficiency virus type-1 infected children.

Abstract:

BACKGROUND: Data on adherence to and acceptability of once daily lamivudine and abacavir are few. METHODS: Twenty-four U.K. human immunodeficiency virus type-1 infected children 2-13 years of age participated in the Pediatric European Network for the Treatment of AIDS (PENTA) 13 single arm, open label pharmacokinetic study of twice (every 12 hours) versus once (every 24 hours) daily lamivudine and abacavir. Caregivers were asked to complete an adherence questionnaire at screening, week 0 (swi...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


Journal:
Pediatric infectious disease journal More from this journal
Volume:
25
Issue:
6
Pages:
533-537
Publication date:
2006-06-01
DOI:
EISSN:
1532-0987
ISSN:
0891-3668

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP